findmyKOL

Robert Pelz, MD

Basic profile

Infectious Disease

ORCIDNone on fileNPI
RegionSpringfield, OR · WestSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Robert Pelz is an Infectious Disease physician. OpenAlex indexes 31 publications with 895 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
31publications

Distinct works indexed by OpenAlex.

895citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3377 Riverbend Dr
Springfield, OR 974778800

Telephone

541-242-5245

Registry record last updated 20 Nov 2009.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    45.3%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor12%
    Tivicay72%Dovato9%Isentress8%Juluca6%Isentress Hd5%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor8.6%
    Descovy45%Abacavir-Lamivudine15%Emtricitabine-Tenofovir Disop14%Triumeq13%Abacavir8%Emtricitabine6%
    Part D<11 patients

    + 14 more classes in this area

  • Cardiovascular

    24.5%
    Statin8.4%
    Atorvastatin Calcium77%Rosuvastatin Calcium17%Pravastatin Sodium7%
    Part D<11 patients
    Beta blocker3%
    Metoprolol Succinate56%Carvedilol27%Propranolol Hcl17%
    Part D<11 patients

    + 10 more classes in this area

  • Nervous system

    16.1%
    SSRI3.5%
    Escitalopram Oxalate44%Trazodone Hcl42%Fluvoxamine Maleate14%
    Part D<11 patients
    Opioid Agonist2.4%
    Oxycodone Hcl50%Methadone Hcl25%Morphine Sulfate Er25%
    Part D<11 patients

    + 7 more classes in this area

Where care is delivered (Part B)74.5% facility · 25.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”